Monthly Archives: June 2011

Parliamentary Declaration on Access to Medicines and Other Pharmaceutical Products

Today, the 35 Parliamentarians meeting at the Global Fund Parliamentary Forum in Sao Paulo, Brazil adopted a very powerful Declaration on access to medicines – the Sao Paulo Parliamentary Declaration on Access to Medicines and other Pharmaceutical Products. The Declaration … Continue reading

Posted in Investment treaties, TRIPS | Leave a comment

Anti-Counterfeiting Trade Agreement

ACTA has just been sent to the EU Council for its signature, before going to national parliaments and then European Parliament. ACTA has been determined a “mixed agreement”! This means each of 27 EU members state parliaments must ratify ACTA. … Continue reading

Posted in ACTA | Leave a comment

Flawed agreement – BMS Matrix agreement on AIDS drug

Bristol-Myers Squibb and Matrix sign New Agreement to limit access to Atazanavir – Bristol-Myers Squibb (BMS) on June 28 (2011) announced that it had signed an immunity-from suit agreement with Matrix Laboratories. The Mylan Company subsidiary already manufactures  atazanavir and its … Continue reading

Posted in Uncategorized | Leave a comment

IPR negotiations in TPPA

Seventh round of negotiations of Trans Pacific Partnership Agreement took place from June 15- 24 in Vietnam. We have mentioned in previous postings that US is planning to table TRIPS plus provisions including data exclusivity, patent term extension, patent linkages. To read the … Continue reading

Posted in data exclusivity, Generic drug, Patent linkages, Patent Term Extension, TPPA, Trans-Pacific Partnership Agreement, TRIPS plus | Leave a comment

Bitter pill for multinationals

Economic Times Blog Amiti Sen, June 28, 2011 Civil society organisations protesting against the possibility of India tightening its intellectual property regime to benefit EU pharma companies could take a short break. It is more or less official now that India … Continue reading

Posted in data exclusivity, EU-India FTA, Generic drug, TRIPS plus | Leave a comment

Border Measures – EU targets export of generic medicines once again

EU has not dropped its plans to prevent export of generic medicines from India to other developing countries. MSF has posted new details on the border measures negotiations in the EU India FTA. Read briefing document here.

Posted in EU-India FTA, IPR Enforcement, TRIPS plus, Uncategorized | Leave a comment

Why India should rethink its investment treaties

El Salvador sued under investor state arbitration clause of the Central America Free Trade Agreement. The New York Times reports that after a mining project in El Salvador failed to launch, thwarted investors started heading to international courts to seek out lost profits. … Continue reading

Posted in BITS, Investment treaties | Leave a comment

Wellington Public Forum On The TPP

Wellington activists are hosting a public forum to focus attention and generate critical debate on the Trans Pacific Partnership Agreement (TPP), a trade and investment agreement currently under negotiation. Speakers include Jane Kelsey (University of Auckland), Des O’Dea (University of … Continue reading

Posted in TPPA | Leave a comment

US industry aiming for investment treaty with India

Now the US corporate world is eyeing for an investment treaty with India. There have not been any good precedents of countries’ benefiting by signing investment treaty with US. America Inc calls for bilateral investment treaty with India  PTI, Fri, Jun 24, 2011 From … Continue reading

Posted in BITS, Investment treaties | 1 Comment

U.S. BREAKS UN AIDS SUMMIT COMMITMENT ON ACCESS TO TREATMENT AIDS

Groups outraged as US declares war on generic AIDS medicines through Free Trade Agreement Negotiations with Vietnam and Malaysia 23 June 2011, Bangkok and Ho Chi Minh – The Asia Pacific Network of Positive People (APN+) is expressing outrage at … Continue reading

Posted in FTAs, TPPA, Trans-Pacific Partnership Agreement, TRIPS | Leave a comment